SG11202104713RA - Pyridazinone compounds and uses thereof - Google Patents
Pyridazinone compounds and uses thereofInfo
- Publication number
- SG11202104713RA SG11202104713RA SG11202104713RA SG11202104713RA SG11202104713RA SG 11202104713R A SG11202104713R A SG 11202104713RA SG 11202104713R A SG11202104713R A SG 11202104713RA SG 11202104713R A SG11202104713R A SG 11202104713RA SG 11202104713R A SG11202104713R A SG 11202104713RA
- Authority
- SG
- Singapore
- Prior art keywords
- pyridazinone compounds
- pyridazinone
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862756553P | 2018-11-06 | 2018-11-06 | |
| PCT/US2019/060157 WO2020097266A1 (en) | 2018-11-06 | 2019-11-06 | Pyridazinone compounds and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202104713RA true SG11202104713RA (en) | 2021-06-29 |
Family
ID=69160036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202104713RA SG11202104713RA (en) | 2018-11-06 | 2019-11-06 | Pyridazinone compounds and uses thereof |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US11091464B2 (en) |
| EP (2) | EP4248973A3 (en) |
| JP (2) | JP7162132B2 (en) |
| KR (1) | KR20210100094A (en) |
| CN (1) | CN113272291A (en) |
| AU (1) | AU2019376065A1 (en) |
| BR (1) | BR112021008905A2 (en) |
| CA (1) | CA3118934A1 (en) |
| DK (1) | DK3877376T3 (en) |
| EA (1) | EA202191084A1 (en) |
| ES (1) | ES2958954T3 (en) |
| FI (1) | FI3877376T3 (en) |
| HR (1) | HRP20231389T1 (en) |
| HU (1) | HUE063586T2 (en) |
| IL (1) | IL282998A (en) |
| LT (1) | LT3877376T (en) |
| MX (2) | MX2021005350A (en) |
| PL (1) | PL3877376T3 (en) |
| PT (1) | PT3877376T (en) |
| RS (1) | RS64828B1 (en) |
| SG (1) | SG11202104713RA (en) |
| SI (1) | SI3877376T1 (en) |
| WO (1) | WO2020097266A1 (en) |
| ZA (1) | ZA202103260B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU231285B1 (en) | 2018-04-18 | 2022-08-28 | Printnet Kereskedelmi És Szolgáltató Kft. | Compounds for selectively inhibiting myosin ii isoforms |
| PL3877052T3 (en) * | 2018-11-06 | 2024-02-05 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| EA202191084A1 (en) | 2018-11-06 | 2021-10-19 | Эджвайз Терапьютикс, Инк. | COMPOUNDS OF PYRIDAZINONES AND THEIR APPLICATIONS |
| JP2022506686A (en) | 2018-11-06 | 2022-01-17 | エッジワイズ セラピューティクス， インコーポレイテッド | Pyridadinone compounds and their use |
| EP4149620B1 (en) * | 2020-05-13 | 2024-10-23 | Edgewise Therapeutics, Inc. | Pyridazinone compounds for the treatment of neuromuscular diseases |
| WO2021231572A1 (en) * | 2020-05-13 | 2021-11-18 | Edgewise Therapeutics, Inc. | Pyridazinone compounds for the treatment of neuromuscular diseases |
| WO2021231615A1 (en) * | 2020-05-13 | 2021-11-18 | Edgewise Therapeutics, Inc. | Substituted pyridazinone for use in the treatment of neuromuscular diseases |
| WO2021231546A1 (en) * | 2020-05-13 | 2021-11-18 | Edgewise Therapeutics, Inc. | Substituted pyridazinone for use in the treatment of neuromuscular diseases |
| WO2021231630A1 (en) * | 2020-05-13 | 2021-11-18 | Edgewise Therapeutics, Inc. | Substituted pyridazinone for use in the treatment of neuromuscular diseases |
| EP4433473A1 (en) * | 2021-11-17 | 2024-09-25 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| WO2023220180A1 (en) * | 2022-05-11 | 2023-11-16 | Edgewise Therapeutics, Inc. | Methods of manufacturing pyridazinone compounds |
| WO2024055007A1 (en) | 2022-09-09 | 2024-03-14 | Edgewise Therapeutics, Inc. | Pyridazinone compositions for the treatment of neuromuscular conditions |
| WO2024146559A1 (en) * | 2023-01-04 | 2024-07-11 | 西藏海思科制药有限公司 | Pyridazinone heterocyclic compound myosin ii inhibitor and use thereof |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6140270A (en) | 1984-08-01 | 1986-02-26 | Morishita Seiyaku Kk | Pyridazinone derivative |
| DD286354A5 (en) | 1989-08-08 | 1991-01-24 | Karl-Marx-Universitaet Leipzig,De | PROCESS FOR PREPARING SUBSTITUTED 2-CARBAMOYL-METHYL-4-PHENYL-1,2,5,6-TETRAHYDRO- AND 1,2-DIHYDRO-1-OXO-PYRIDAZINE |
| EP0478195B1 (en) | 1990-09-21 | 1999-05-26 | Rohm And Haas Company | Dihydropyridazinones and pyridazinones as fungicides |
| AU707748B2 (en) | 1994-03-25 | 1999-07-22 | Isotechnika Inc. | Enhancement of the efficacy of drugs by deuteration |
| US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| IL118631A (en) | 1995-06-27 | 2002-05-23 | Tanabe Seiyaku Co | Pyridazinone derivatives and processes for their preparation |
| DE19629817A1 (en) | 1996-07-24 | 1998-01-29 | Hoechst Ag | New imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| PL358057A1 (en) | 2000-06-05 | 2004-08-09 | Altana Pharma Ag | Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
| KR20050105982A (en) | 2003-03-07 | 2005-11-08 | 코와 가부시키가이샤 | Benzofuran derivative |
| JP4890439B2 (en) | 2005-03-07 | 2012-03-07 | 杏林製薬株式会社 | Pyrazolopyridin-4-ylpyridazinone derivatives and their addition salts and PDE inhibitors containing them as active ingredients |
| WO2007044796A2 (en) | 2005-10-11 | 2007-04-19 | Nps Pharmaceuticals, Inc. | Pyridazinone compounds as calcilytics |
| DE102005057924A1 (en) | 2005-12-05 | 2007-06-06 | Merck Patent Gmbh | pyridazinone derivatives |
| SI2069312T1 (en) | 2006-07-25 | 2013-03-29 | Cephalon, Inc. | Pyridizinone derivatives |
| CA2676173A1 (en) | 2007-02-16 | 2008-08-28 | Amgen Inc. | Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors |
| DE102007025717A1 (en) | 2007-06-01 | 2008-12-11 | Merck Patent Gmbh | Aryl ether pyridazinone derivatives |
| DE102007025718A1 (en) | 2007-06-01 | 2008-12-04 | Merck Patent Gmbh | pyridazinone derivatives |
| DE102007032507A1 (en) | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | pyridazinone derivatives |
| DE102007038957A1 (en) | 2007-08-17 | 2009-02-19 | Merck Patent Gmbh | 6-thioxo-pyridazine derivatives |
| DE102008019907A1 (en) | 2008-04-21 | 2009-10-22 | Merck Patent Gmbh | pyridazinone derivatives |
| WO2010048149A2 (en) | 2008-10-20 | 2010-04-29 | Kalypsys, Inc. | Heterocyclic modulators of gpr119 for treatment of disease |
| AR081626A1 (en) * | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | AMINO-PYRIDAZINIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME TO TREAT CARDIAC AND SKELETIC MUSCULAR DISORDERS |
| AR081331A1 (en) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | AMINO- PYRIMIDINES COMPOSITIONS OF THE SAME AND METHODS FOR THE USE OF THE SAME |
| WO2012021707A2 (en) | 2010-08-11 | 2012-02-16 | The Regents Of The University Of California | Premature-termination-codons readthrough compounds |
| ES2537190T3 (en) | 2010-09-01 | 2015-06-03 | Gilead Connecticut, Inc. | Pyridazinones, preparation procedure and procedures for their use |
| US8759380B2 (en) | 2011-04-22 | 2014-06-24 | Cytokinetics, Inc. | Certain heterocycles, compositions thereof, and methods for their use |
| EP2768826A1 (en) | 2011-10-17 | 2014-08-27 | Bayer Intellectual Property GmbH | Substituted oxadiazolyl pyridinones and oxadiazolyl pyridazinones as hif inhibitors |
| CN103570730A (en) | 2012-08-01 | 2014-02-12 | 中国科学院上海药物研究所 | Condensed ring pyridazinone compound with bridge ring structure as well as preparation method and application thereof |
| WO2014031928A2 (en) | 2012-08-24 | 2014-02-27 | Philip Jones | Heterocyclic modulators of hif activity for treatment of disease |
| US9566310B2 (en) * | 2012-09-10 | 2017-02-14 | Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno | Methods of treating muscular dystrophy |
| US9216180B2 (en) | 2012-10-02 | 2015-12-22 | New York University | Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated RNA decay |
| EP2935253B1 (en) | 2012-12-21 | 2018-08-01 | Zenith Epigenetics Ltd. | Novel heterocyclic compounds as bromodomain inhibitors |
| ES2634627T3 (en) | 2013-02-07 | 2017-09-28 | Merck Patent Gmbh | Pyridazinone Amide Derivatives |
| CA2906008C (en) | 2013-03-13 | 2019-07-09 | Flatley Discovery Lab, Llc | Pyridazinone compounds and methods for the treatment of cystic fibrosis |
| CN106467495A (en) * | 2015-08-19 | 2017-03-01 | 中国科学院上海药物研究所 | Pyridazinone compound, its preparation method, pharmaceutical composition and purposes |
| US20190256474A1 (en) | 2016-10-26 | 2019-08-22 | Proteostasis Therapeutics, Inc. | N-phenyl-2-(3-phenyl-6-oxo-1,6-dihydropyridazin-1-yl)acetamide derivatives for treating cystic fibrosis |
| US20190248765A1 (en) * | 2016-10-26 | 2019-08-15 | Proteostasis Therapeutics, Inc. | Compounds, compositions, and methods for increasing cftr activity |
| US20190248779A1 (en) | 2016-10-26 | 2019-08-15 | Proteostasis Therapeutics, Inc. | Compounds, compositions, and methods for increasing cftr activity |
| CN110573161A (en) | 2017-03-28 | 2019-12-13 | 勃林格殷格翰国际有限公司 | Nintedanib for use in a method of treating muscular dystrophy |
| TW202334101A (en) | 2017-04-06 | 2023-09-01 | 美商富曼西公司 | Fungicidal oxadiazoles |
| US20180303821A1 (en) | 2017-04-24 | 2018-10-25 | BraneQuest, Inc. | Membrane active molecules |
| BE1025518B1 (en) | 2017-08-30 | 2019-04-03 | E2 Drives Sa | Powertrain |
| CN111556747B (en) | 2017-10-27 | 2023-11-17 | 索尼克马斯特有限公司 | DUX 4-induced inhibitors for modulating muscle function |
| EP3794151A4 (en) | 2018-05-17 | 2022-03-23 | Bolt Threads, Inc. | Sec modified strains for improved secretion of recombinant proteins |
| AU2019282231A1 (en) | 2018-06-04 | 2021-01-14 | Ohio State Innovation Foundation | EAAT2 activators and methods of using thereof |
| JP7476100B2 (en) | 2018-07-19 | 2024-04-30 | 住友ファーマ株式会社 | Pyridazinone Derivatives |
| CN108947912B (en) | 2018-07-31 | 2021-10-01 | 中国人民解放军总医院 | Neddylation pathway targeted anti-tumor compound |
| EA202191084A1 (en) | 2018-11-06 | 2021-10-19 | Эджвайз Терапьютикс, Инк. | COMPOUNDS OF PYRIDAZINONES AND THEIR APPLICATIONS |
| JP2022506686A (en) * | 2018-11-06 | 2022-01-17 | エッジワイズ セラピューティクス， インコーポレイテッド | Pyridadinone compounds and their use |
| PL3877052T3 (en) * | 2018-11-06 | 2024-02-05 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| WO2021231615A1 (en) | 2020-05-13 | 2021-11-18 | Edgewise Therapeutics, Inc. | Substituted pyridazinone for use in the treatment of neuromuscular diseases |
| WO2021231546A1 (en) | 2020-05-13 | 2021-11-18 | Edgewise Therapeutics, Inc. | Substituted pyridazinone for use in the treatment of neuromuscular diseases |
| EP4149620B1 (en) | 2020-05-13 | 2024-10-23 | Edgewise Therapeutics, Inc. | Pyridazinone compounds for the treatment of neuromuscular diseases |
| WO2021231630A1 (en) | 2020-05-13 | 2021-11-18 | Edgewise Therapeutics, Inc. | Substituted pyridazinone for use in the treatment of neuromuscular diseases |
| WO2021231572A1 (en) | 2020-05-13 | 2021-11-18 | Edgewise Therapeutics, Inc. | Pyridazinone compounds for the treatment of neuromuscular diseases |
| EP4433473A1 (en) | 2021-11-17 | 2024-09-25 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
| WO2024055007A1 (en) | 2022-09-09 | 2024-03-14 | Edgewise Therapeutics, Inc. | Pyridazinone compositions for the treatment of neuromuscular conditions |
-
2019
- 2019-11-06 EA EA202191084A patent/EA202191084A1/en unknown
- 2019-11-06 EP EP23189000.5A patent/EP4248973A3/en active Pending
- 2019-11-06 FI FIEP19835997.8T patent/FI3877376T3/en active
- 2019-11-06 PL PL19835997.8T patent/PL3877376T3/en unknown
- 2019-11-06 DK DK19835997.8T patent/DK3877376T3/en active
- 2019-11-06 JP JP2021524227A patent/JP7162132B2/en active Active
- 2019-11-06 CA CA3118934A patent/CA3118934A1/en active Pending
- 2019-11-06 ES ES19835997T patent/ES2958954T3/en active Active
- 2019-11-06 LT LTEPPCT/US2019/060157T patent/LT3877376T/en unknown
- 2019-11-06 KR KR1020217016684A patent/KR20210100094A/en unknown
- 2019-11-06 WO PCT/US2019/060157 patent/WO2020097266A1/en active Application Filing
- 2019-11-06 AU AU2019376065A patent/AU2019376065A1/en active Pending
- 2019-11-06 SI SI201930610T patent/SI3877376T1/en unknown
- 2019-11-06 HU HUE19835997A patent/HUE063586T2/en unknown
- 2019-11-06 RS RS20231080A patent/RS64828B1/en unknown
- 2019-11-06 BR BR112021008905-5A patent/BR112021008905A2/en unknown
- 2019-11-06 MX MX2021005350A patent/MX2021005350A/en unknown
- 2019-11-06 HR HRP20231389TT patent/HRP20231389T1/en unknown
- 2019-11-06 PT PT198359978T patent/PT3877376T/en unknown
- 2019-11-06 CN CN201980088114.7A patent/CN113272291A/en active Pending
- 2019-11-06 EP EP19835997.8A patent/EP3877376B1/en active Active
- 2019-11-06 SG SG11202104713RA patent/SG11202104713RA/en unknown
-
2020
- 2020-11-03 US US17/088,469 patent/US11091464B2/en active Active
-
2021
- 2021-05-06 MX MX2024004531A patent/MX2024004531A/en unknown
- 2021-05-06 IL IL282998A patent/IL282998A/en unknown
- 2021-05-13 ZA ZA2021/03260A patent/ZA202103260B/en unknown
- 2021-06-11 US US17/345,909 patent/US12012395B2/en active Active
-
2022
- 2022-10-17 JP JP2022166276A patent/JP7429750B2/en active Active
-
2023
- 2023-09-01 US US18/460,464 patent/US20240025879A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202103260B (en) | Pyridazinone compounds and uses thereof | |
| ZA202103231B (en) | Pyridazinone compounds and uses thereof | |
| IL273236A (en) | Pyrazolopyrimidinone compounds and uses thereof | |
| IL285178A (en) | Compounds and uses thereof | |
| GB201803568D0 (en) | Novel compounds and uses | |
| GB201714745D0 (en) | New compounds and uses | |
| IL285177A (en) | Compounds and uses thereof | |
| GB201714740D0 (en) | New compounds and uses | |
| GB201714734D0 (en) | New compounds and uses | |
| IL286497A (en) | Compounds and uses thereof | |
| IL277502A (en) | Compounds and uses thereof | |
| IL291499A (en) | Aza-quinoline compounds and uses thereof | |
| IL279483A (en) | Cyanotriazole compounds and uses thereof | |
| IL285118A (en) | Compounds and uses thereof | |
| IL284764A (en) | Compounds and uses thereof | |
| IL280644A (en) | Magnesium-serinate compound and use thereof | |
| GB201714736D0 (en) | New compounds and uses | |
| GB201812078D0 (en) | Novel compounds and their uses | |
| GB201712110D0 (en) | New compounds and uses | |
| GB201801102D0 (en) | New compounds and uses | |
| IL280369A (en) | New myokines and uses thereof | |
| GB201806349D0 (en) | New compounds and uses | |
| ZA202201239B (en) | Aminothiolester compounds and uses thereof | |
| GB201810667D0 (en) | New compounds and uses | |
| IL283540A (en) | Dock1-inhibiting compound and use thereof |